The best of EcoWatch, right in your inbox. Sign up for our email newsletter!
Special Interests Threaten FDA's Ability to Make Science-Based Decisions
The pharmaceutical, medical device and biotechnology industries together spent more than $700 million in lobbying from 2009 through 2011, according to an analysis from the Center for Responsive Politics commissioned by the Union of Concerned Scientists.
Pharmaceuticals companies and related trade groups spent more than $487 million on lobbying over this three-year period, while biotechnology firms and their trade groups spent more than $126 million and device manufacturers and their trade groups spent more than $86 million.
By comparison, the oil and gas industry spent more than $467 million and the insurance industry spent nearly $481 million during the same three-year period.
While these companies differ in their specific objectives, a central lobbying target for all of them is the Food and Drug Administration (FDA), which must evaluate new drugs and medical devices for safety and efficacy as well as monitor them after they enter the market.
“All this money skews the debate and diminishes the public’s voice on these issues,” said Francesca Grifo, director of the Union of Concerned Scientists’ Scientific Integrity Program. “What’s at stake here is FDA’s ability to make independent, science-based decisions that affect our health and safety.”
The analysis comes as the Senate Health, Education, Labor and Pensions Committee held a hearing on March 29 on draft legislation to amend and approve an agreement between the FDA and medical products companies that governs how the agency approves drugs and devices. The companies have agreed to pay fees to the agency, and in exchange the FDA has agreed to meet certain performance standards in the review process, including a timeline for device and drug reviews. Congress must act on the legislation this year.
The analysis also showed that these industries were generous with their campaign contributions, giving nearly $6.3 million to 70 lawmakers who served on relevant committees from 2009 through 2011.
This year, several industry-friendly proposals are pending in both the House and Senate, including legislation that would reduce the FDA’s scrutiny of medical devices, relax conflict-of-interest standards at the agency, and emphasize speed and innovation over adherence to the FDA’s science-based standards for safe and effective drugs and devices.
“These industry-friendly legislative proposals, many of which will roll back reforms Congress approved in a bipartisan manner just five years ago, raise significant concerns about the increasing impact of special interests in our democratic process,” said Celia Wexler, Washington representative for the Scientific Integrity program. “Those interests are now threatening the role science plays in guiding policy that directly impacts public health.”
UCS is tracking several issues related to the roles of science and corporate interests at FDA, and conducted a recent survey of agency scientists and staff regarding industry influence and political interference in scientific work. Click here to view the survey’s results.
For more information, click here.
EcoWatch Daily Newsletter
Native Americans are disproportionately without access to clean water, according to a new report, "Closing the Water Access Gap in the United States: A National Action Plan," to be released this afternoon, which shows that more than two million Americans do not have access to access to running water, indoor plumbing or wastewater services.
By Nanticha Ocharoenchai
In the Czech Republic, horses have become the knights in shining armor. A study published in the Journal for Nature Conservation suggests that returning feral horses to grasslands in Podyjí National Park could help boost the numbers of several threatened butterfly species.
By Bailey Hopp
If you had to choose a diamond for your engagement ring from below or above the ground, which would you pick … and why would you pick it? This is the main question consumers are facing when picking out their diamond engagement ring today. With a dramatic increase in demand for conflict-free lab-grown diamonds, the diamond industry is shifting right before our eyes.
By Whitney E. Akers
- "The Game Changers" is a new documentary on Netflix that posits a vegan diet can improve athletic performance in professional athletes.
- Limited studies available show that the type of diet — plant-based or omnivorous — doesn't give you an athletic advantage.
- We talked to experts about what diet is the best for athletic performance.
Packed with record-setting athletes displaying cut physiques and explosive power, "The Game Changers," a new documentary on Netflix, has a clear message: Vegan is best.